CMS Rule Seeks to More Clearly Define Internal Coverage Criteria, AI-Driven Tools

  • Dec 05, 2024

    Multiple industry experts say the current administration’s last major Medicare Advantage and Part D rulemaking attempt was largely “business as usual,” with CMS expanding on policies of the Joe Biden presidency and digging further into persistent issues like utilization management (UM), misleading marketing and provider directory accuracy. And they say it’s likely that some — but not all — provisions will make it into the final rule, which would be released by the incoming Republican administration under President-elect Donald Trump.

    “It certainly seems like this was written as if there was going to be another Democratic administration, as the overall trend of CMS regulatory policymaking in the last four years” has been to further regulate MA, observes Tricia Beckmann, principal with Faegre Drinker Consulting. “Some of the provisions are probably an overreach in so far as they don’t align with what we think is the posture of the Trump administration versus some areas that are potentially tricky,” such as UM and insurers’ reported use of artificial intelligence to deny claims, which has drawn concern from both sides of the aisle and from providers, she points out.

    Read more
    © 2024 MMIT
  • Lauren Flynn Kelly

    Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

The Latest
Meet Our Reporters

Meet Our Reporters

×